




Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta-analysis
Running title: Soft drinks and adverse cardiovascular disease and mortality
Aditya Narain,1 Chun Shing Kwok MBBS MSc BSc,1,2 Mamas A Mamas BM BCh DPhil1,2,3 
1. Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom 
2. University Hospital of North Midlands, Stoke-on-Trent, UK 
3. Farr Institute, University of Manchester, Manchester, UK 
Corresponding author: 
Aditya Narain
Keele Cardiovascular Research Group
Institute for Science & Technology in Medicine,
Keele University,
Guy Hilton Research Centre,
Thornburrow Drive, Hartshill,
Stoke-on-Trent, UK, ST4 7QB
Tel: +44 (0) 1782 671653
Fax: +44 (0) 1782 674467
Mail to: aditya@hotmail.co.uk
Keywords: Sweetened beverages; Acute Myocardial infarction; Stroke, Mortality; Meta-analysis
Disclosures: None.




Background: Soft drink consumption is associated with adverse health behaviours whichthat predispose to adverse coronary heartcardiovascular diseaserisk factor profiles; however, it is unclear whether their intake independently leads to an increased risk of cardiovascular events and mortality. It is controversial whether consumption of sweetened beverages is associated with an increased risk of adverse cardiovascular events and mortality. AWe conducted a systematic review and meta-analysis was conducted to evaluate evaluate the relationship between sweetened beverages and cardiovascular events and mortalitythis.
Methods: Medline and EMBASE were searched in July 2015 for studies that considered soft drink intake their association with and risk of mortality, myocardial infarction (MI) or stroke.  Pooled risk ratios for adverse outcomes were calculated using inverse variance with a random effects model, and heterogeneity was assessed using the I2 statistic.
Results: A total of 87 prospective cohort studies with 308,810420 participants (age range 34-75 years) were included in the review.  The pooled results suggest a significant increase in stroke greater risk of stroke (RR 1.13 95%CI 1.02-1.24), and MI (RR 1.22 95%CI 1.14-1.30), but not vascular events with incremental increase in sugar-sweetened beverage (SSB) consumption. For stroke, there were significant increases with greater incremental increase in artificially sweetened beverage (ASB consumption (stroke RR With incremental increase in artificially sweetened beverage (ASB) consumption, there was a greater risk of stroke (RR 1.08 95%CI 1.03-1.14), but not vascular events or MI.  In the evaluation of high versus low SSB, there was a significant increase a greater risk of MI (RR 1.19 95%CI 1.09-1.31) but not for stroke, vascular events or mortality. For ASB, there was a significantly increase in greater risk of stroke (RR 1.14 95/%CI 1.04-1.26) and vascular events (RR 1.44 95%CI 1.02-2.03) but not MI or mortality.





Inclusion criteria: Studies which evaluated the association between soft drink consumption and adverse cardiovascular outcomes were selected. No restrictions were placed on definition or method of ascertaining soft drink consumption. Studies had to evaluate two or more groups of beverage consumers and adverse outcomes (myocardial infarction, stroke, cardiovascular events or mortality).  There was no restriction based on study design, study cohort and language of study report.

Message for the Clinic




	The burden associated with cardiovascular disease is significant. Since it is the number one cause of mortality worldwide, there is an increasing emphasis on primary and secondary prevention; expenditure within the European Union totals nearly €196 billion a year [1-3].  Soft drinks can be categorisedcategorized into sugar-sweetened beverages (SSB) or artificially sweetened beverages (ASB). The impact of SSB intake on cardiovascular disease and mortality is garnering interest in the media and amongst policy makers, with several international societies recommending a reduction in SSB consumption [4,5]. Currently, there are no guidelines related to artificially sweetened beverage consumption. 
	Sugar-sweetened beverage consumption Consumption of both sugar-sweetened and artificially sweetened beverages has been is associated with a greater risk of developing an adverse with the development of cardio-metabolic risk factor profiles. A meta-analysis of 7 prospective cohort studies found one daily serving increment of SSBs to be associated with 0.22kg (95%CI 0.09-0.34kg) weight gain over one year [6]. Both SSB and ASB intake has been associated with a greater risk of incidencet of type-2 diabetes independently of adiposity; a meta-analysis of 17 prospective cohort studies found a higher consumption of SSB/ASB by one serving per day conferred a greater risk of developing type-2 diabetes (RR 1.28 95%CI 1.12-1.46; RR 1.29 95%CI 1.08-1.54 respectively). such as weight gain and type-2 diabetes [6,[7]. Similarly, associations between artificially sweetened beverage intake and type-2 diabetes mellitus have been characterised [7]. In addition, a meta-analysis of 6 prospective cohort studies including 240,726 participants found SSB intake to be positively associated with risk of hypertension (RR 1.10 95%CI 1.06-1.15) [8]. Similarly, an analysis of three large prospective cohorts found SSB/ASB consumption to confer a greater risk of incident hypertension (aHR 1.13 95%CI 1.09-1.17; aHR 1.14 95%CI 1.09-1.18 respectively) both types of sweetened beverage were found to be associated with an increased risk of incident hypertension in a study investigating three large prospective cohorts [89]. 
Despite the well-characterisedcharacterized association between sweetened beverage intake and development of an adverse cardio-metabolic risk factorsfactor profile, the relationship between sweetened beverage intake and cardiovascular disease and mortality is more controversial. A study of 13,624 individuals from a Californian retirement community found those in the highest tertile of ASB, but not SSB, consumption to have a greater an increased risk of mortality with artificially sweetened beverage intake (RR 1.18 95%CI 1.07-1.30), but not with sugar-sweetened beverage intake [910].  These findings were not reflected in 2 prospective cohort studies (the Health Professionals’ Follow-up Study and Nurses’ Health Study), where individuals who consumed ≥2 servings of SSB per day had a greater risk of mortality (HR 1.18 95% CI 1.04-1.33) than those who consumed <1/month; consumption of ASBs had no effect on mortality risk. However, conflicting results were observed in 2 prospective cohort studies (the Health Professionals’ Follow-up Study and Nurses’ Health Study) where an increased risk of mortality with sugar-sweetened beverage intake (HR 1.18 95% CI 1.04-1.33), but not with artificially sweetened beverage consumption was observed [1011]. There are further studies, such as the Singapore Chinese Health Study, which included 52,584 participants and reported no significant association between sugar-sweetened beverages intake and mortality [1112]. 
With reference to cardiovascular disease, a prospective cohort study of 42,883 malesby de Koning et al. in 2012 found found individuals SSB, but not ASB, consumption to be associated with a greater risk of an increased risk of coronary heart disease with SSB intake (RR 1.18 95%CI 1.06-1.31), but not with ASB consumption [1213]; ]. whereas In contrast, a prospective cohort study of 39,786 Japanese participants by Eshak et al. in 2012 found no association between sweetened beveragesoft drink consumption and ischemic heart disease after 18 years of follow-up [1314]. 





	Prospective Sstudies which evaluated the association between soft drink consumption and adverse cardiovascular outcomes were selected. No restrictions were placed on definition or method of ascertaining soft drink consumption. Studies had to evaluate two or more groups of beverage consumers and adverse outcomes (myocardial infarction (MI), stroke, cardiovascular events or mortality).  There was were no restrictions based on based on study design (e.g. retrospective, prospective), study cohort and or language of study report.
Search strategy
	MEDLINE and EMBASE were searched using Ovid SP with no date or language restriction in July 2015 using the broad search terms in Figure 1. Furthermore, researchers screened bibliographies of potentially relevant studies and reviews for additional studies.
Study selection and data extraction
	Two reviewers (AN and CSK) screened all titles and abstracts for studies that met the inclusion criteria and excluded any articles that did not clearly fulfil the selection criteria. Full-texts of potentially relevant studies were downloaded and assessed. Final decisions on inclusion or exclusion were made with discussion with a third reviewer (MAM). Two extractors (AN and CSK) independently collected data from included studies on study design, study date, country of origin, sample size, participant age, gender and inclusion criteria, population characteristics, risk of bias, definition of sweetened beverage or soda consumption, follow-up and results.
Risk of bias assessment
	Risk of bias was evaluated by considering 5 categories: reliable exposure ascertainment, reliable outcome ascertainment, lost loss-to follow up, use of adjustment for potential confounders and generalisabilitygeneralizability of findings. 
	Publication bias was considered using asymmetry testing if there were more than 10 studies in a particular the meta-analysis, and if statistical heterogeneity was <50% [1415].
Data analysis
	RevMan 5.025 (Nordic Cochrane Centre) was used to conduct random effects meta-analysis using inverse variance method for pooled risk ratios (RR). Where possible, adjusted risk estimates from the primary studies were pooled, otherwise raw outcome data was used to yield unadjusted risk estimates. As continuous continues variables were available, analysis evaluating risk of adverse outcomes per unit or serving increase of soft drink intake was performed. Furthermore, where multiple groups were reported, extreme groups (i.e. the highest quantity of consumption of sweetened beverages or soft drinks compared to the lowest) were pooled, as this increased likelihood of detecting potential associations. The analysis was split into sugar-sweetened beverage consumption and artificially sweetened (diet or low-calorie) beverage consumption. A sensitivity analysis was performed excluding studies which did not adjust for body mass index.   
Statistical heterogeneity




	From the total 303 studies screened for this review, 10 9 articles.[910-1314,1617-2021] were included. These reported results from 8 7 unique studies (Nurse’s Health Study and Health Professionals Follow-up Study were reported on multiple occasions for different outcomes) [6,1213,1617,1718].  The process of study selection is shown in Figure 1.  
Study design and participant characteristics
	All included studies were prospective cohort studies except for the case-control study by Nicknam et al [20]. Although the majority of studies were conducted in the USA, some were conducted in Japan, Sweden, Iran and Singapore.  These studies took place between 1980 and 2011. The total number of participants from the 8 7 unique studies was 308,810420. The number of participants in each study ranged from 390 2,564 to 88,520 and ages of participants in the 5 studies that reported age ranges was between 34 and 75 years. The percentage of male participants in the studies ranged from 32% to 5452%, aside from two studies, one comprising of all males and the other all females. The study design and participant characteristics are shown in Table 1.  Supplementary Table 1 shows participant characteristics according to beverage consumption. Participants who consumed higher amounts of sugar-sweetened beverages were more likely to be smokers and exercise less.

Risk of bias
	Table 2 shows the risk of bias of included studies. All 8 7 studies used a food frequency questionnaire or survey to evaluate beverage intake. Outcome ascertainment was reliable in all studies; methods used include direct contact with patients, evaluation of medical records and checking death registries. Outcomes studied were MI, stroke and mortality. Of the 8 7 unique studies, the percentage of participants lost to follow-up was unclear in 54; the remaining three studies reported a loss to follow-up <10%. All studies adjusted for age, sex, smoking and physical activities in their analysis. Other frequently adjusted variables include body mass index, alcohol intake, diet and family history. One study which did not adjust for body mass index was excluded in a sensitivity analysis. A total of 3 studies were conducted in general populations, whereas the remainder used specific cohorts such as male health professionals or female nurses, or ethnicities such as Chinese, Iranian orChinese or Japanese populations.  

Study results
Table 3 shows the results of included studies. Sweetened beverages were categorized most commonly into sugar-sweetened and artificially sweetened. Artificially sweetened beverages included low-calorie and diet sodas. A total of two studies use MI as an outcome, while two other studies use coronary heart disease (defined as fatal or nonfatal MI). Stroke featured as an outcome of 4 studies, and mortality in 3. Follow-up ranged from a case-control 9.8study to 24 years. 3 studies provided data to show the effects of an incremental increase in sweetened beverages on MI, stroke and mortality. All 8 7 studies provided a high versus low table in their results. 
The Nurse’s Health Study and the Health Professionals Follow-up Study cohorts were investigated in more than one included study. These articles were included despite studying the same cohorts because each study evaluated different outcomes. 
Studies of incremental increase in sugar sweetened beverages or artificially sweetened beverages and adverse outcomes
	  Figure 2 shows the risk of adverse outcomes with incremental increase in sugar sweetened beverage intake. The pooled results suggest a one-serving per day increase in SSB consumption was associated with a greater risk of stroke (RR 1.13 95%CI 1.02-1.24) and MI (RR 1.22 95%CI 1.14-1.30), but not of vascular events. significant increase in stroke RR 1.13 95%CI 1.02-1.24, and MI RR 1.22 95%CI 1.14-1.30, but not vascular events with sugar sweetened beverage consumption.  For these analyses there was little evidence of statistical heterogeneity as the respective I2 values for stroke and coronary heart disease MI were 0% and 8% respectively.
Figure 3 shows the risk of adverse outcomes with incremental increase in artificially sweetened beverage intake. The pooled results suggest a one-serving per day increase in ASB consumption was associated with a greater risk of stroke (RR 1.08 95%CI 1.03-1.14), but not of MI or vascular events. a significant increase in stroke RR 1.08 95%CI 1.03-1.14, but not myocardial infarction or vascular events with artificially sweetened beverage consumption.    
Studies of high versus low consumption of sugar-sweetened beverages or artificially sweetened beverages and adverse outcomes
	Figure 4 shows the risk of adverse outcomes with high versus low intake of sugar-sweetened beverages. The pooled results of 6 studies show SSB consumption to be associated with a greater risk of MI (RR 1.19 95%CI 1.09-1.31), but no effect on risk of stroke, vascular events or mortality.
	Figure 5 shows the risk of adverse outcomes with high versus low intake of artificially-sweetened beverages. The pooled results of 2 studies suggest increased risk of stroke ASB consumption is associated with a greater risk of stroke (RR 1.14 95%CI 1.04-1.26) and the results from one study suggest a greater risk of vascular events (RR 1.44 95% CI 1.02-2.03). No significant difference was observed for MI or mortality. 
Figure 6 shows the risk of stroke with high versus low intake of sugar-sweetened beverages. The analysis is stratified by type of stroke (ischemic or hemorrhagic) and gender. After gender stratification and consideration of stroke type there appeared to be no significant difference in risk for men with ischemic stroke or men and women with hemorrhagic stroke.  However, sugar-sweetened beverage intake seems to significantly increase risk of ischaemic stroke in women However, pooled results suggest that women who consume SSBs have a greater risk of ischemic stroke (RR 1.33 95%CI 1.07-1.66).




		Our results suggest that soft drink consumption is associated with increased risk of cardiovascular events. The risk increases with dose and applies to both sugar- and artificially sweetened beverages. Our pooled estimates suggest that SSB intake confers a 19% greater risk of MI, with 22% increased risk associated with each additional serving per day. Furthermore, we found a 33% increased risk of stroke associated with SSB consumption. In comparison, ASB consumption was found to increase risk of stroke and vascular events (14% and 44% respectively), with risk of stroke exhibiting an 8% dose-related increase. Neither sugar nor artificially sweetened beverage intake was associated with increased mortality. 
Our results suggest that soft drink consumption is associated with a dose-dependent greater risk of cardiovascular events and this applies to both sugar- and artificially sweetened drinks. Our pooled estimates suggest that SSB intake is associated with a 19% greater risk of MI, with each additional daily serving associated with 22% greater risk. Furthermore, we report a 33% greater risk of stroke associated with increased SSB consumption. In comparison, ASB consumption was independently associated with a greater risk of stroke and vascular events (14% and 44% respectively), with each additional daily serving associated with an 8% greater risk of stroke. Neither sugar- nor artificially sweetened beverage intake was associated with mortality. 
Sugar-sweetened beverage consumption has been associated with the development of cardio-metabolic risk factors such as weight gain and type-2 diabetes and non-alcoholic fatty liver disease (NAFLD) [6,7,21]. Similarly, associations between artificially sweetened beverage intake and type-2 diabetes mellitus have been characterized [7]. Few studies have examined the association between sugar-, or artificially, sweetened beverage consumption and risk of coronary heart disease, stroke and mortality. A meta-analysis conducted by Huang et al. found a 17% increased risk of coronary heart disease in individuals within the highest group of sugar-sweetened beverage intake compared to the lowest [22]. However, this meta-analysis did not evaluate the risk of stroke or mortality with SSB consumption. Moreover, there were concerns regarding the analysis – the prospective study carried out by Gardener (2012) was included in analysis despite measuring a composite of vascular outcomes (stroke, coronary heart disease and vascular death) rather than coronary heart disease [18]. Furthermore, the impact of artificially sweetened drinks was not considered by this meta-analysis. 
Sugar-sweetened beverage consumption has been associated with the development of cardio-metabolic risk factors such as weight gain and type-2 diabetes and non-alcoholic fatty liver disease (NAFLD) [6,7,2121,22]. Similarly, associations between artificially sweetened beverage intake and type-2 diabetes mellitus have been characterized [7]. Few studies have examined the association between sugar-, or artificially, sweetened beverage consumption and risk of coronary heart disease, stroke and mortality. A meta-analysis of 4 prospective cohort studies conducted by Huang et al. found a positive association between SSB consumption and risk of developing coronary heart disease; individuals within the highest group of SSB intake had a 17% greater risk of CHD than those in the lowest [2223]. However, this meta-analysis did not evaluate the risk of stroke or mortality with SSB consumption. Moreover, there were concernsare limitations regarding theto this analysis – the prospective study carried out by Gardener et al (2012) was included in analysis despite measuring a composite of vascular outcomes (stroke, coronary heart disease and vascular death) rather than coronary heart disease [1819]. Furthermore, the impact of artificially sweetened drinks was not considered by this meta-analysis. 
There are several possible mechanisms by which sugar-sweetened beverage intake may result in adverse cardiovascular health outcomes. Sweetened beverage consumption may serve as a surrogate of an unhealthy diet and lifestyle. Individuals who consumed sugar-sweetened beverages more frequently were more likely to consume increased amounts of saturated fat, meat and sugar and less fruit, fiber and wholegrain foods [17,23]. Individuals with this diet pattern were also likely to smoke, have lower physical activity levels, a higher body mass index and watch more hours of television than those with a healthier diet [17,23]. However, in a prospective cohort study examining the relationship between sweetened beverage consumption and coronary heart disease in women, even following adjustment using the Alternative Healthy Eating Index (AHEI), which measures the healthfulness of a diet, individuals who consumed the greatest amounts of SSB had a combined RR for stroke of 1.35 (1.07-1.69). In addition, of the 10 studies included in this meta-analysis, 9 adjust for dietary factors, body mass index and physical activity and 6 for total energy intake (see Table 2). 
The findings of this meta-analysis may be explained in a number of ways. Firstly, There are several possible mechanisms by which sugar-sweetened beverage intake may result in adverse cardiovascular health outcomes. Sweetened soft drinkbeverage consumption may serve as a surrogate of an unhealthy diet and lifestyle. Individuals who consumed sugar-sweetened beverages more frequently were more likely to consume increased amounts of saturated fat, meat and sugar and less fruit, fiber and wholegrain foods [1718,2324]. Individuals with this diet pattern were also likely to smoke, have lower physical activity levels, a higher body mass index and watch more hours of television than those with a healthier diet [1718,2324].  However, in a prospective cohort study examining the relationship between sweetened beverage consumption and coronary heart disease in women, even following adjustment using the Alternative Healthy Eating Index (AHEI), which measures the healthfulness of a diet, individuals in the highest quintile of consumption (≥2 servings per day) of SSB had a combined RR for CHD of 1.35 (1.07-1.69). In addition, of the 9 studies included in this meta-analysis, 8 adjust for body mass index and physical activity, 7 for dietary factors, and 5 for total energy intake (see Table 2). 
A possible mechanism explainingSecondly, sugar-sweetened beverage intake may increase the risk of cardiovascular disease through associated increases in the risk of future obesity and diabetes development risk with sugar-sweetened beverage intake is that consumption leads to obesity, increasing risk of diabetes mellitus. Development of diabetes mellitus, in turn, increases risk of cardiovascular disease. Carbohydrates in a liquid form have a lower effect on satiety than solid carbohydrates [2425]. Decreased satiety from consuming these “empty” calories means more food is consumed, contributing to weight gain and subsequent obesity. This aberrant compensation in caloric intake at meal times was observed in a study which showed increased dietary consumption following isocaloric intake soft drinks of compared with food [25]. A reduction in sweetened beverage intake is associated with weight loss. In a randomized, controlled, behavioral intervention trial that studied the impact of a reduction in sweetened beverage consumption on weight, a 1 serving per day reduction in sugar-sweetened beverage intake was associated with 0.65kg weight loss at 18 months [26]. Finally, other mechanisms have also been hypothesized. 
Sugar-sweetened beverages are often sweetened by high-fructose corn syrup. Following absorption, fructose enters the glycolytic pathway, which yields products essential for ATP production and lipogenesis. This pathway is regulated by negative feedback via downstream products (glycerol 3-phosphate and acetyl CoA). However, fructose enters the glycolytic pathway after the level of inhibition and hence fructose metabolism is less regulated compared to glucose. Excessive products of fructose metabolism may lead to increased lipogenesis and subsequent deposition of visceral and intramuscular fat [2726]. A study comparing daily intake of cola, diet cola, milk or water for 6 months found cola consumption promoted intramuscular and visceral fat deposition compared with the other beverages [28]. Furthermore, fructose, unlike other sugars, has been found to increase uric acid levels [2927]. Increased serum uric acid levels have been found to reduce endothelial nitric oxide (NO) activity [3028]. Endothelial NO improves blood flow to skeletal muscle and is important for glucose uptake; decrease in NO activity induces insulin resistance [3129]. Insulin resistance and dyslipidemia induced by fructose intake serve to increase the risk of cardiovascular disease [3230]. 
Sugar-sweetened beverages have a high glycemic index and a high glycemic load may lead to inflammation and insulin resistance [3331]. Inflammation may be triggered by hyperglycemic spikes that lead to oxidative stress, depletion of the anti-oxidant glutathione and release of pro-inflammatory cytokines [3432]. Results from a prospective study of 42,883 participants found sugar-sweetened beverage consumption to be associated with increased serum levels of C-reactive protein, interleukin-6 and tumor necrosis factors r1 and r2 [1213]. Inflammation is important in the pathophysiology of metabolic disorders, may contribute to atherosclerosis and therefore to an increased risk of cardiovascular disease [3533]. 
Similarly, the risks associated with ASB consumption may be explained in a number of ways. Reverse causality Reverse confounding may be importantexplain the association between ASBs and cardiovascular disease; participants with pre-existent cardio-metabolic risk factors may intentionally switch to ASB consumption. artificially sweetened beverages may be more likely to be consumed by obese and diabetic participants, who themselves have an increased risk of cardiovascular complications. For example, in the study of Gardener et al, those with more vascular risk factors had a greater intake of artificially sweetened beverages at baseline [1819]. The prospective study of 42,883 men followed as part of the Health Professionals Follow-up Study adjusted for prior weight change and dieting – a factor which may have motivated people to switch from sugar-sweetened to artificially sweetened beverages [1213]. None of the other studies included in this meta-analysis adjusted for this variable and therefore results may be heavily confounded. Alternatively, ASB intake may itself increase risk of cardiovascular disease through predisposition to obesity; artificial sweeteners may bind to intestinal sweet-taste receptors and stimulate release of incretin hormones, which promote appetite and weight gain [34-36]. 
The majority of studies included in this analysis used baseline food frequency questionnaires to quantify sweetened beverage intake. Some of these studies did not re-survey dietary preferences for the remainder of follow-up [1112,1819,1920]. This may have produced additional confounding. Furthermore, seasonal variations in the intake of sweetened beverages may bias the data collected by studies that quantify beverage intake over the last month rather than the last year [1314]. 
Studies were also susceptible to misclassification errors – participant interpretation of a serving size of sweetened beverage may have varied. Furthermore, these errors could be further compounded by the location of study, for example, there is a wider range and larger portion size of soft drinks in the USA compared to Japan [1112,1314]. 
Results may have been further confounded in 4 3 out of the 10 9 studies included in this meta-analysis which did not sub-classify sweetened beverage intake into sugar-sweetened and artificially sweetened [1112,1314,1920,20].
A few studies had limited external validity because they contained specific groups or participants were dissimilar to the general population. For example, the study by Fung (2009) follows a cohort of 88,520 female nurses [1718]. Another cohort containing 32,883 male health professionals was analyzed by de Koning (2012) [1213]. These two cohorts were also used in the studies by Bernstein (2012) and Malik (2014) [1011,1617]. 
This study considers the impact of both sugar- and artificially sweetened beverages on risk of cardiovascular disease and mortality. To the best of our knowledge, no meta-analyses in the current literature consider this. Further strengths of the present study include the large sample size, long follow-up duration and adjustment for important variables such as diet, physical activity, body mass index, age, sex, family history, smoking and cardiovascular risk factors by many of the included studies. However, different confounders were adjusted for in each study. The results of this study may be underestimated, as the majority of included studies adjust for variables such as BMI, history of diabetes and hypertension – which may be part of the causal model for the association between sweetened beverages and cardiovascular disease. In addition, there may be residual confounding, where unmeasured factors exhibit an effect on the results (for example, socio-economic level). All the studies included in the analysis may be contaminated by residual confounding; sweetened beverage consumption may interact with unmeasured variables. For example, in the study carried out by Fung (2009), sugar-sweetened beverage consumption was correlated with intake of food rich in fat. Some studies do not take into account dietary intake of fat and may therefore have residual confounding. 
The current study is limited by the reporting of existing studies. As this study does not use primary data, it relies on published data for its analyses. Publication bias may affect the results of this study–a propensity to publish positive findings rather than negative would skew the results of this study.  
In conclusion, current literature suggests there may be an association between sugar-sweetened beverage intake and cardiovascular disease. People who are at risk of, or already have, cardiovascular disease should consider limiting consumption of sugar-sweetened beverages. Our results add to the growing body of evidence suggesting consumption of these beverages is detrimental to those at risk of cardiovascular disease but more studies are needed. Furthermore, these results support public health initiatives and guidelines to reduce sugar-sweetened beverage consumption. 
In conclusion, the pooled results from this meta-analysis show that sugar- or artificially sweetened beverage consumption is independently associated with a greater risk of incident cardiovascular disease. Whilst such associations cannot infer causality, soft drink consumption may act as a proxy for adverse health behaviors or may be associated with adverse the cardio-metabolic risk factor profile that may contribute to the associations reported. Our results support public health initiatives and guidelines to reduce sugar-sweetened beverage consumption and other adverse lifestyle factors associated with sugar- or artificially sweetened beverage consumption should be targeted. 
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Table 1: Study design and participant characteristics
Study ID	Study design; Country; Year	No. of participants	Mean age (years)	% Male	Participants inclusion criteria	Exposure 
Bernstein 2012	Two prospective cohort studies; USA; 1980-2008.	84,085 women, 43,371 men.	n/a	34%	Participants were females in the Nurses’ Health Study and males from the Health Professionals Follow-up Study.	SSB and ASB.
de Koning 2012	Prospective cohort study; USA; 1986-2008.	42, 883 men.	Age range 40-75.	100%	Participants were males from the Health Professionals Follow-up Study.	SSB and ASB.
Eshak 2012	Prospective cohort study; Japan; 1990-2007.	39, 786 participants(20, 911 women, 
18, 875 men,).	Age range 40-59.	47%	Participants were Japanese men and women aged between 40 and 59 in the Japan Public Health Centre-based prospective study on cancer and cardiovascular disease Cohort I. 	Soft drink.
Fung 2009	Prospective cohort study; USA; 1980-2004.	88, 520 women.	Age range 34-59.	0%	Participants were females from the Nurses’ Health Study. 	SSB and ASB.
Gardener 2012	Prospective cohort study; USA; 1993-2011.	2,564 participants.	69.	36%	Participants were men and women from the Northern Manhattan Study.	SSB and ASB.
Larsson 2014	Two prospective cohort studies; Sweden; 1997-2008.	32, 575 women, 35, 884 men.	n/a	52%	Participants were females from the Swedish Mammography Cohort and males from the Cohort of Swedish Men.	Sweetened beverage.
Malik 2014	Two prospective cohort studies; USA; 1980-2010.	82, 592 women, 38, 602 men.	n/a	32%	Participants were females in the Nurses’ Health Study and males from the Health Professionals Follow-up Study.	SSB and ASB.
Odegaard 2015	Prospective cohort study; Singapore; 1993-2011.	52, 584 participants.	Age range 45-74	44%	Participants were Chinese men and women from the Singapore Chinese Health Study.	Soft drinks.
Paganini-Hill 2007	Prospective cohort study; USA; 1981-2004.	13, 624 participants (8, 644 women, 4, 980 men).	Median age 74.	37%	Participants were men and women from the Leisure World Cohort Study.	SSB and ASB.




Table 2: Quality assessment of included studies
Study ID	Reliable exposure ascertainment	Reliable outcome ascertainment	Lost to follow up <10%	Variables adjusted for in analysis	Generalizability of findings
Bernstein 2012	Yes, Food frequency questionnaire was used.	Yes, Data from medical records, interviews, letters and state vital records, the National Death Index, next of kin or postal system.	Unclear.	Age, calendar time, dietary intake, smoking, alcohol, parental history of early myocardial infarction, multivitamin use, aspirin use, vitamin E supplement, menopausal status, use of hormone replacement therapy, physical exercise, sugar-sweetened and low-calorie sodas, body mass index and energy intake.	No, Female nurses and male health professionals.
de Koning 2012	Yes, Semi-quantitative food frequency questionnaire was used. 	Yes, incident IHD (fatal or nonfatal myocardial infarction) diagnosed from biennial questionnaires, medical records. Deaths confirmed using the National Death Index, next of kin, and reports from participants’ professional organizations. Cause of death ascertained by autopsy reports ± death certificates.	Yes, 94% response rate to baseline and biennial questionnaires.	Smoking, physical activity, alcohol intake, multivitamin use, family history of coronary heart disease, pre-enrolment (1981-1986) weight gain or loss, adherence to a low-calorie diet, total energy intake, body mass index, alternative Healthy Eating Index, age, smoking, family history of type 2 diabetes, past diagnosis of coronary heart disease, self-reported high triglycerides, high cholesterol and high blood pressure. 	No, Male health professionals. 
Eshak 2012	Yes, Food frequency questionnaire was used which was validated by 7 day weighted dietary records.	Yes, Stroke was diagnosed on the examination of data from CT scan, MR images or autopsy and MI was confirmed on medical records, ECG, cardiac enzymes or autopsy.	Unclear.	Age, history of hypertension, history of diabetes, smoking status, alcohol intake, leisure-time sports activity, job status, quintiles of energy-adjusted dietary intakes of selected foods and nutrients (seafood, meat, fruit and sodium), body mass index and total energy intake.	No, Japanese population generalizable to Asian population.
Fung 2009	Yes, Food frequency questionnaire was used. 	Yes, Myocardial infarction ascertained using biennial patient questionnaire and confirmed by reviewing medical records (ECG changes, elevated cardiac enzymes), autopsy or death certificate.Death identified by using state vital statistics records, the National Death Index, next of kin or postal system.	Yes, Follow-up was complete for >95% of the potential person-time up to 2004. 	Age, smoking, alcohol intake, parental history of myocardial infarction before age 60 years, aspirin use, physical activity, history of hypertension and high blood cholesterol, menopausal status and postmenopausal hormone use and Alternative Healthy Eating Index.	No, Female nurses.
Gardener 2012	Yes, Food frequency questionnaire administered by interview.	Yes, participants screened to determine changes in vital status or detect neurological events from annual telephone calls, with screen-positive participants having an in-person assessment with chart review and physician examination. Mortality and morbidity data also from surveillance of hospital admission and discharge data.	Unclear.	Age, sex, race/ethnicity, education, smoking, physical activity, alcohol consumption, diet, body mass index, previous cardiac disease, peripheral vascular disease, metabolic syndrome, history of diabetes, history of hypercholesterolemia, history of hypertension, blood sugar, low density lipoprotein cholesterol, high density lipoprotein cholesterol, systolic and diastolic blood pressure, anti-hypertensive medication use, type of soft drink.	Yes, population in Northern Manhattan. 
Larsson 2014	Yes, Semi-quantitative food frequency questionnaire was used. 	Yes, Incident stroke ascertained from linkage of the study population to the Swedish Inpatient Register and the Swedish Cause of Death Register.	Unclear.	Education, age, sex, family history of myocardial infarction before 60 years of age, smoking, total physical activity, body mass index, history of hypertension, aspirin use, total energy intake, alcohol consumption and dietary intake (coffee, dairy products, fruits, vegetables, chocolate, fish, unprocessed and processed red meat).	Yes, participants from general Swedish population.
Malik 2014	Yes, Food frequency questionnaire was used.	Unclear method of mortality ascertainment.	Unclear.	Body mass index, baseline diabetes, hypertension, hypercholesterolemia, major dietary and lifestyle risk factors.	No, Female nurses and male health professionals.
Odegaard 2015	Yes, Past-year semi-quantitative food frequency questionnaire was used.	Yes, Data for mortality through linkage with the nationwide registry of birth and death in Singapore with the primary cause of death used for analysis.	Unclear.	Age, sex, dialect, education, year of interview, smoking, moderate and vigorous activity, sleep, body mass index, hypertension, nonbeverage vegetable-fruit-soy-rich dietary pattern score and energy intake.	No, Chinese population generalizable to Asian population.




Table 3: Dietary assessments used, follow up and results for included studies (aHR = adjusted Hazard Ratio; aRR= adjusted Relative Risk)
Study ID	Dietary assessment used	Outcomes evaluated and follow-up	Results
Bernstein 2012	Food frequency questionnaire for sugar-sweetened soda and low-calorie soda.	Stroke, ischemic stroke and hemorrhagic stroke at 22 to 28 years follow-up.	Sugar-sweetened soda and risk of stroke in:Men: none HR 1.00, up to once/week aHR 0.93 (0.80-1.08), up to once/day aHR 0.99 (0.86-1.14), once or more than one/day aHR 1.08 (0.82-1.41), incremental increase 1/serving/d RR 1.08 (0.89-1.32).Women: none aHR 1.00, up to once/week aHR 1.00 (0.91-1.10), up to once/day aHR 1.11 (1.00-1.22), once or more than one/day aHR 1.19 (1.00-1.42), incremental increase 1/serving/d RR 1.14 (1.02-1.27).Low-calorie soda and risk of stroke in:Men: none aHR 1.00, up to once/week aHR 0.92 (0.78-1.09), up to once/day aHR 1.02 (0.89-1.17), once or more than one/day aHR 1.08 (0.91-1.30), incremental increase 1/serving/d RR 1.07 (0.97-1.19).Women: none aHR 1.00, up to once/week aHR 1.00 (0.89-1.12), up to once/day aHR 1.09 (0.99-1.21), once or more than one/day aHR 1.17 (1.04-1.31), incremental increase 1/serving/d RR 1.09 (1.02-1.16).Sugar-sweetened soda and risk of ischemic stroke in:Men: none aHR 1.00, up to once/week aHR 0.90 (0.75-1.08), up to once/day aHR 0.89 (0.74-1.06), once or more than one/day aHR 1.02 (0.72-1.45), incremental increase 1/serving/d RR 1.00 (0.77-1.30).Women: none aHR 1.00, up to once/week aHR 1.05 (0.92-1.20), up to once/day aHR 1.18 (1.02-1.35), once or more than one/day aHR 1.28 (0.99-1.65), incremental increase 1/serving/d RR 1.19 (1.01-1.39).Pooled: none aHR 1.00, up to once/week aHR 1.00 (0.89-1.11), up to once/day aHR 1.06 (0.95-1.18), once or more than one/day aHR 1.19 (0.97-1.46), incremental increase 1/serving/d RR 1.13 (0.99-1.30).Sugar-sweetened soda and risk of hemorrhagic stroke in:Men: none aHR 1.00, up to once/week aHR 0.75 (0.51-1.11), up to once/day aHR 1.21 (0.86-1.71), once or more than one/day aHR 0.82 (0.38-1.77), incremental increase 1/serving/d RR 1.10 (0.66 – 1.81).Women: none aHR 1.00, up to once/week aHR 0.95 (0.75-1.19), up to once/day aHR 1.00 (0.79-1.26), once or more than one/day aHR 0.85 (0.56-1.29), incremental increase 1/serving/d RR 0.92 (0.71-1.20).Pooled: none aHR 1.00, up to once/week aHR 0.90 (0.73-1.09), up to once/day aHR 1.06 (0.88-1.29), once or more than one/day aHR 0.85 (0.59-1.22), incremental increase 1/serving/d RR 0.96 (0.76-1.21).Low-calorie soda and risk of ischemic stroke in:Men: none aHR 1.00, up to once/week aHR 0.95 (0.77-1.17), up to once/day aHR 0.98 (0.82-1.17), once or more than one/day aHR 1.10 (0.87-1.38), incremental increase 1/serving/d RR 1.08 (0.95-1.24).Women: none aHR 1.00, up to once/week aHR 1.05 (0.90-1.23), up to once/day aHR 1.08 (0.94-1.24), once or more than one/day aHR 1.15 (0.97-1.35), incremental increase 1/serving/d RR 1.06 (0.97-1.16).Pooled: none aHR 1.00, up to once/week aHR 1.01 (0.89-1.15), up to once/day aHR 1.04 (0.93-1.16), once or more than one/day aHR 1.13 (0.99-1.29), incremental increase 1/serving/d RR 1.07 (0.99-1.15).Low-calorie soda and risk of hemorrhagic stroke in:Men: none aHR 1.00, up to once/week aHR 0.77 (0.50-1.20), up to once/day aHR 1.00 (0.72-1.41), once or more than one/day aHR 1.05 (0.66-1.67), incremental increase 1/serving/d RR 1.08 (0.82-1.43).Women: none aHR 1.00, up to once/week aHR 0.96 (0.72-1.28), up to once/day aHR 1.08 (0.85-1.37), once or more than one/day aHR 1.55 (1.20-2.00), incremental increase 1/serving/d RR 1.31 (1.15-1.51).Pooled: none aHR 1.00, up to once/week aHR 0.90 (0.71-1.15), up to once/day aHR 1.06 (0.87-1.28), once or more than one/day aHR 1.42 (1.14-1.77), incremental increase 1/serving/d RR 1.27 (1.12-1.43).
de Koning 2012	Semi-quantitative food frequency questionnaire for sugar sweetened (caffeinated colas, caffeine-free colas, other carbonated sugar-sweetened beverages, non-carbonated sugar-sweetened beverages [fruit punches, lemonades or other fruit drinks]) and artificially sweetened (caffeinated low-calorie beverages, non-carbonated low-calorie beverages) beverages. 	Coronary heart disease (nonfatal or fatal MI) at biennial follow-up over 22 years.	Risk of coronary heart disease with sugar-sweetened beverages:Never: aRR 1.00, 2/month aRR 1.03 (0.94-1.13), 1-4/week: aRR 1.05 (0.95-1.15), 4.5/week-7.5/day: aRR 1.18 (1.06-1.31).Risk of coronary heart disease with artificially sweetened beverages:Never: aRR 1.00, 2/month aRR 0.90 (0.82-1.00), 1-4/week: aRR 0.92 (0.84-1.00), 4.5/week-7.5/day: aRR 0.98 (0.90-1.09).Risk of coronary heart disease per serving of sugar-sweetened beverage:Total sugar-sweetened beverages: Mean Servings per Day 0.36 (0.61), Relative Risk for 1 Serving per Day  aRR 1.19 (1.11-1.28).Colas: Mean Servings per Day 0.21, Relative Risk for 1 Serving per Day aRR 1.19 (1.09-1.31).Carbonated noncolas: Mean Servings per Day 0.07 (0.20), Relative Risk for 1 Serving per Day aRR 1.25 (1.04-1.51).Fruit punches, lemonades and other noncarbonated fruit drinks: Mean Servings per Day 0.08 (0.27), Relative Risk for 1 Serving per Day aRR 1.25 (1.08-1.46).Risk of coronary heart disease per serving of artificially sweetened beverage:Total artificially sweetened beverages: Mean Servings per Day 0.49 (0.94), Relative Risk for 1 Serving per Day aRR 1.05 (1.00-1.10).Colas: Mean Servings per Day 0.37 (0.80), Relative Risk for 1 Serving per Day aRR 1.03 (0.97-1.09).Carbonated noncolas: Mean Servings per Day 0.11 (0.33), Relative Risk for 1 Serving per Day aRR 1.20 (1.07-1.35).
Eshak 2012	Food frequency questionnaire for soft-drink intake.	Stroke, ischemic stroke, hemorrhagic stroke and MI at follow-up over 18 years. 	Risk of stroke with soft drink intake:Men: Never or rarely aHR1.00, 1-2 cups/week aHR0.89 (0.78-1.05), 3-4 cups/week aHR0.90 (0.76-1.06), Almost every day aHR0.76 (0.62-1.06).Women: Never or rarely aHR 1.00, 1-2 cups/week aHR 1.07 (0.91-1.25), 3-4 cups/week aHR 1.12 (0.87-1.44), Almost every day aHR 1.21 (0.88-1.68).Risk of hemorrhagic stroke with soft drink intake:Men: Never or rarely aHR 1.00, 1-2 cups/week aHR 1.02 (0.82-1.26), 3-4 cups/week aHR 1.03 (0.78-1.35), Almost every day aHR 0.77 (0.55-1.08).Women: Never or rarely aHR 1.00, 1-2 cups/week aHR 1.09 (0.87-1.36), 3-4 cups/week aHR 1.13 (0.80-1.58), Almost every day aHR 0.70 (0.40-1.20).Risk of ischemic stroke with soft drink intake:Men: Never or rarely aHR 1.00, 1-2 cups/week aHR 0.85 (0.71-1.01), 3-4 cups/week aHR 0.68 (0.51-0.89), Almost every day aHR 0.75 (0.53-1.03).Women: Never or rarely aHR 1.00, 1-2 cups/week aHR 1.03 (0.82-1.30), 3-4 cups/week aHR 1.12 (0.78-1.63), Almost every day aHR 1.83 (1.22-2.75).Risk of ischemic heart disease with soft drink intake:Men: Never or rarely aHR 1.00, 1-2 cups/week aHR 0.85 (0.66-1.08), 3-4 cups/week aHR 0.85 (0.61-1.18), Almost every day aHR 1.04 (0.74-1.48).Women: Never or rarely aHR 1.00, 1-2 cups/week aHR 0.96 (0.59-1.55), 3-4 cups/week aHR 1.52 (0.78-2.95), Almost every day aHR 0.88 (0.30-2.60).
Fung 2009	Food frequency questionnaire for sugar-sweetened beverages (caffeinated and non-caffeinated colas [e.g. Coke, Pepsi, and other colas with sugar], other carbonated beverages with sugar [e.g. 7-Up], noncarbonated sweetened beverages [i.e. Hawaiian Punch, lemonade and other carbonated fruit drinks]) and artificially sweetened beverages (including low-calorie drinks). 	Coronary heart disease (nonfatal or fatal MI) at biennial follow-up over 24 years. 	Sugar-sweetened beverage intake and risk of coronary heart disease: <1/month aRR 1.00, 1 to 4/month aRR 0.96 (0.87-1.06), 2 to 6/week aRR 1.04 (0.95-1.14), 1 to <2/day aRR 1.23 (1.06-1.43), ≥2/day 1.35 (1.07-1.69).Incremental increase in 2-servings of specific sugar-sweetened beverage consumption and risk of coronary heart disease: Total sugar-sweetened beverages aRR 1.28 (1.14-1.44), Colas aRR 1.35 (1.15-1.57), Carbonated noncola aRR 1.27 (0.87-1.86), Fruit drinks and punch aRR 1.33 (1.03-1.71).Artificially sweetened beverage intake and risk of coronary heart disease: <1/monthaRR 1.00, 1 to 4/month aRR 0.92 (0.82-1.03), 2 to 6/week aRR 0.98 (0.90-1.07), 1 to <2/day aRR 1.03 (0.90-1.17), ≥2/day aRR 1.15 (0.97-1.38).
Gardener 2012	Food frequency questionnaire for consumption of diet soft drinks and regular soft drinks. 	Stroke, MI, or vascular death at a mean follow-up of 9.8 years. 	Regular soft drinks and risk of vascular events: noneaHR 1.00, 1/month to 6/week aHR 0.87 (0.71-1.07), 1+/dayaHR 1.09 (0.82-1.46)Continuous regular soft drinks/week aHR 1.00 (0.98-1.02).Diet soft drinks and risk of vascular events: none aHR 1.00, 1/month to 6/week aHR 1.08 (0.85-1.37), 1+/day aHR 1.44 (1.02-2.02), continuous regular soft drinks/week aHR 1.02 (1.00-1.05).Regular soft drinks and risk of vascular events among those healthier at baseline: none aHR 1.00, 1/month to 6/week aHR 0.93 (0.68-1.25), 1+/day aHR 1.57 (1.05-2.35), Healthy at baseline continuous regular soft drinks/week: aHR 1.02 (0.99-1.04).Diet soft drinks and risk of vascular events among those healthier at baseline: none aHR 1.00, 1/month to 6/week aHR 0.94 (0.62-1.41), 1+/day aHR 1.59 (0.92-2.74), Healthy at baseline continuous diet soft drinks/week aHR 1.03 (1.00-1.07).
Larsson 2014	Semi-quantitative food frequency questionnaire for sweetened beverages.	Stroke with a mean follow-up of 10.3 years. 	Sweetened beverage consumption and risk of stroke in:Women: 0 servings/day aRR 1.02 (0.88-1.17), 0.1 to <0.5 servings/day aRR 1.00, 0.5 to <1.0 servings/day aRR 0.90 (0.69-1.18), 1.0 to <2.0 servings/day aRR 1.06 (0.88-1.30), ≥2 servings/day aRR 1.14 (0.92-1.41).Men: 0 servings/day aRR 1.11 (0.96-1.27), 0.1 to <0.5 servings/day aRR 1.00, 0.5 to <1.0 servings/day aRR 1.13 (0.92-1.39), 1.0 to <2.0 servings/day aRR 1.17 (0.98-1.39), ≥2 servings/day aRR 1.22 (1.02-1.45).Pooled: 0 servings/day aRR 1.07 (0.97-1.18), 0.1 to <0.5 servings/day aRR 1.00, 0.5 to <1.0 servings/day aRR 1.04 (0.89-1.22), 1.0 to <2.0 servings/day aRR 1.12 (0.99-1.28), ≥2 servings/day aRR 1.19 (1.04-1.36).Sweetened beverage consumption and risk of cerebral infarction in: Women: 0 servings/day aRR 1.02 (0.86-1.21), 0.1 to <0.5 servings/day aRR 1.00, 0.5 to <1.0 servings/day aRR 0.93 (0.68-1.27), 1.0 to <2.0 servings/day aRR 1.11 (0.88-1.39), ≥2 servings/day aRR 1.17 (0.91-1.49).Men: 0 servings/day aRR 1.03 (0.88-1.21), 0.1 to <0.5 servings/day aRR 1.00, 0.5 to <1.0 servings/day aRR 1.12 (0.88-1.42), 1.0 to <2.0 servings/day aRR 1.12 (0.91-1.36), ≥2 servings/day aRR 1.25 (1.02-1.53).Pooled: 0 servings/day aRR 1.03 (0.92-1.16), 0.1 to <0.5 servings/day aRR 1.00, 0.5 to <1.0 servings/day aRR 1.05 (0.87-1.27), 1.0 to <2.0 servings/day aRR 1.10 (0.96-1.29), ≥2 servings/day aRR 1.22 (1.04-1.42).Sweetened beverage consumption and risk of hemorrhagic stroke in: Women: 0 servings/day aRR 1.03 (0.73-1.46), 0.1 to <0.5 servings/day aRR 1.00, 0.5 to <1.0 servings/day aRR 0.79 (0.39-1.57), 1.0 to <2.0 servings/day aRR 0.76 (0.44-1.31), ≥2 servings/day aRR 0.94 (0.54-1.66).Men: 0 servings/day aRR 1.16 (0.82-1.63), 0.1 to <0.5 servings/day aRR 1.00, 0.5 to <1.0 servings/day aRR 0.89 (0.53-1.51), 1.0 to <2.0 servings/day aRR 1.25 (0.83-1.89), ≥2 servings/day aRR 1.10 (0.71-1.71).Pooled 0 servings/day aRR 1.10 (0.87-1.41), 0.1 to <0.5 servings/day aRR 1.00, 0.5 to <1.0 servings/day aRR 0.85 (0.56-1.29), 1.0 to <2.0 servings/day aRR 1.06 (0.77-1.46), ≥2 servings/day aRR 1.07 (0.76-1.51).
Malik 2014	Food frequency questionnaire for sugar-sweetened beverages and artificially sweetened beverages.	Total and cardiovascular disease mortality over 22 year follow-up.	Sugar-sweetened beverages and total mortality: <1/month aHR 1.00, 1 to 4/month aHR 0.95 (0.91-0.98), 2 to 6/week aHR 0.96 (0.93-0.99), 1 to <2/day aHR 1.02 (0.96-1.08), ≥2/day aHR 1.18 (1.04-1.33).Sugar-sweetened beverages and CVD mortality: <1/month aHR 1.00, 1 to 4/month aHR 0.97 (0.90-1.02), 2 to 6/week aHR 0.96 (0.90-1.02), 1 to <2/day aHR 1.04 (0.93-1.16), ≥2/day aHR 1.28 (1.09-1.51).Artificially sweetened beverages and total mortality: <1/month aHR 1.00, 1 to 4/month aHR 0.92 (0.89-0.95), 2 to 6/week aHR 0.91 (0.86-0.97), 1 to <2/day aHR 0.91 (0.86-0.95), ≥2/day aHR 0.99 (0.85-1.15).Artificially sweetened beverages and CVD mortality: <1/month aHR 1.00, 1 to 4/month aHR 0.86 (0.80-0.92), 2 to 6/week aHR 0.87 (0.81-0.94), 1 to <2/day aHR 0.96 (0.88-1.06), ≥2/day aHR 0.96 (0.74-1.25).
Odegaard 2015	Past- year semi-quantitative food frequency questionnaire for soft drinks.	All cause and cardiovascular mortality at median 16.3 person-years follow-up per participant.	Soft drinks and all-cause mortality: none HR 1.00, monthly HR 0.93 (0.87-1.01), 1/week HR 0.94 (0.84-1.04), 2-6/week HR 0.96 (0.87-1.05), ≥1/day HR 0.92 (0.81-1.04).Soft drinks and cardiovascular mortality: none HR 1.00, monthly HR 0.96 (0.84-1.09), 1/week HR 1.08 (0.91-1.30), 2-6/week HR 1.08 (0.92-1.27), ≥1/day HR 1.03 (0.83-1.30).





Supplementary table: sensitivity analysis excluding Fung et al. 

Outcome	Number of studies	Risk ratio (RR 95%CI)
Incremental increase in SSB myocardial infarction	1	1.19 (1.11-1.28)
High vs low SSB myocardial infarction	3	1.16 (1.05-1.29)




303 titles and abstracts retrieved from search of MEDLINE and EMBASE using the search terms: ((soft drink or soda or (sweetened or carbonated or sugary or sugar sweetened or artificially sweetened)) and (drink or beverage)) AND (mortality or death or survival or acute coronary syndrome or myocardial infarction or coronary heart disease or coronary artery disease or ischemic heart disease or ischaemic heart disease or stroke or cerebrovascular disease or cerebrovascular accident or transient ischemic attack or transient ischaemic attack or heart failure or cardiac failure or left ventricular systolic dysfunction).

257 articles were excluded because they clearly did not meet the inclusion criteria.

53 articles were downloaded and reviewed in detail for inclusion.

9 articles were included in final analysis.

44 studies were excluded for the following reasons: no result (n=15), no sugar sweetened beverage (n=12), duplicates (n=4), editorial/letter (n=2), review (n=8), cancer cohort (n=1), case-control study (n=1) and protocol (n=1).



